XPO-1 in Combination With RCHOP for DH/TH Lymphoma

Clinical trial NCT05974085 · UNKNOWN

Trial details

NCT number: NCT05974085
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Double Hit Lymphoma Triple Hit Lymphoma

Start date: 2022-08-01
Primary completion: 2023-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.